Stock listing
NASDAQ:VPHM Viropharma Inc Stock
Follow Viropharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:VPHM
$49.96 USD
Close on Jan 23, 2014 · No longer trades
- Lowest – highest close
- $0.87 – $106.00 USDSince Jan 4, 1999 · lowest Oct 28, 2002 · highest Feb 23, 2000
Delisted NASDAQ:VPHM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:VPHM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Viropharma Inc on 6ix
- Decks
- 5 decks · latest Sep 21, 2012
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (September 2012) | Investor day | 167 slides | Sep 21, 2012 |
| Investor Presentation (January 2010) | Investor deck | 21 slides | Jan 11, 2010 |
| Merger or Acquisition (July 2008) | Merger or acquisition | 29 slides | Jul 15, 2008 |
| SLIDE PRESENTATION | 54 slides | Jan 8, 2008 | |
| Investor Day (October 2006) | Investor day | 34 slides | Oct 25, 2006 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Vincent Milano Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jul 26, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jan 7, 2020); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Aceragen Inc. (Director · Dec 1, 2014 – Aug 10, 2023 · Past); Vanda Pharmaceuticals Inc. (Director · Apr 21, 2010 – Jun 13, 2018 · Past) | President and CEO, Director · Jun 7, 2010 – Jan 24, 2014 · Past |
| John Peter Wolf III Other companies: Nabriva Therapeutics AG (General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past); Aceragen Inc. (General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past) | VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past |
| Robert Pietrusko | VP, Regulatory & Quality · Jun 7, 2010 – Jan 24, 2014 · Past |
Log in to ask 6ix AI your own questions about Viropharma Inc.